Welcome to Professor Melvin Lobo's domain of expertise in cardiovascular medicine, particularly focusing on high blood pressure (hypertension) at Bart’s Blood Pressure Clinic. With a renowned reputation as a Hypertension Centre of Excellence recognized by the European Society, Professor Lobo offers unparalleled expertise and innovative solutions for managing hypertension.
Hypertension, often detected incidentally during routine medical check-ups, is a common concern. Professor Lobo’s clinic provides cutting-edge insights into this condition, presenting the latest advancements and treatment modalities for individuals whose high blood pressure doesn't respond to conventional medication.
Delving into the world of blood pressure disorders, Professor Lobo's clinic addresses the complexities of low and highly variable blood pressure. Through dedicated research and practice, Professor Lobo seeks to unravel the challenges in diagnosing and effectively treating these intricate blood pressure conditions.
With a commitment to advancing cardiovascular medicine, Professor Melvin Lobo stands as a leading authority in high blood pressure, offering new hope and groundbreaking approaches to managing blood pressure disorders that significantly impact millions of individuals. Explore the full profile to access comprehensive information on cutting-edge treatments and innovations in the realm of blood pressure management.
How was your experience with London Blood Pressure & PoTS Clinic?
No name
United Kingdom
04 November, 2023
No name
United Kingdom
02 November, 2023
price on request
price on request
price on request
price on request
Professor Melvin Lobo stands as a prominent figure in the realm of cardiovascular medicine, specializing in the intricate field of hypertension. Renowned as the Director of Bart’s Blood Pressure Clinic, Professor Lobo has earned international recognition as a Hypertension Centre of Excellence accredited by the esteemed European Society of Hypertension. His clinic is a beacon for complex hypertensive cases, drawing referrals nationally and globally due to its exceptional expertise.
Aligned with the prestigious William Harvey Research Institute, Professor Lobo’s clinic has played a pivotal role in groundbreaking studies within the hypertension domain. These include pivotal contributions to landmark studies such as the ASCOT study, which fundamentally impacted UK Hypertension guidelines. Additionally, the clinic's participation in the Symplicity HTN-2 study exploring renal denervation for treatment-resistant hypertension has been revolutionary. Notably, Professor Lobo led the recent ROX Control Hypertension Study, focusing on a novel central iliac arteriovenous anastomosis to address uncontrolled hypertension.
Since October 2011, Professor Lobo has been instrumental in co-hosting and chairing the annual UK Symposia on Renal Denervation at the Royal College of Physicians. Collaborating with a panel of distinguished international authorities in hypertension medicine and interventionists, these symposia have contributed significantly to advancing knowledge and practices in the field.
A key contributor in shaping renal denervation strategies, Professor Lobo serves on the Joint British Societies steering committee on renal denervation. His authored JBS Consensus Statements on Renal Denervation have provided pivotal guidance in this evolving domain. Widely recognized for his expertise, Professor Lobo has delivered extensive lectures and published prolifically on hypertension and innovative therapies for resistant hypertension, enriching the medical community with his wealth of knowledge and insights.
Professor Melvin Lobo's unwavering commitment to advancing hypertension research, coupled with his pivotal role in transforming clinical guidelines and innovative therapies, positions him as a leading authority in cardiovascular medicine, shaping the landscape of hypertension management and treatment worldwide.
